Gilead and Merck initiate phase-II study on Lenacapavir and Islatravir oral combo for HIV-1 treatment in virologically suppressed adults Read more
Cipla Health develops povidone iodine-based anti-viral nasal spray effective against coronavirus Read more
BD launches its second Centre of Excellence in flow cytometry for clinical research at CMC, Vellore Read more
FDA approves Roche’s Susvimo for neovascular or “wet” age-related macular degeneration (nAMD) Read more